Novocure Announces Update on Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-Small Cell Lung CancerBusiness Wire • 04/13/21
Novocure Announces 26 Presentations at American Association for Cancer Research (AACR) Annual Meeting 2021 Suggesting Broad Applicability of Tumor Treating FieldsBusiness Wire • 04/09/21
NovoCure Limited (NVCR) CEO Asaf Danziger on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/25/21
Novocure Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Company UpdateBusiness Wire • 02/25/21
NovoCure (NVCR) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research • 02/18/21
Delcath Systems: Cancer-Treatment Device Company With Upcoming Phase 3 ReadoutSeeking Alpha • 02/09/21
Are Options Traders Betting on a Big Move in NovoCure (NVCR) Stock?Zacks Investment Research • 01/15/21
Novocure Announces Fourth Quarter and Full Year 2020 Preliminary Net Revenues and Provides Company UpdateBusiness Wire • 01/11/21
Novocure to Participate in the 39th Annual J.P. Morgan Virtual Healthcare ConferenceBusiness Wire • 12/23/20
Novocure Announces National Reimbursement in Switzerland for Optune® in Combination With Temozolomide for the Treatment of Newly Diagnosed GlioblastomaBusiness Wire • 12/14/20
First Patient Enrolled in Novocure's Global Phase 3 TRIDENT Trial of Optune® Concurrent with Radiation Therapy in Newly Diagnosed GlioblastomaBusiness Wire • 12/10/20
IBD Stock Of The Day Breaks Out To A Record High As 2021 Catalysts LoomInvestors Business Daily • 12/04/20